1. Home
  2. ACLX vs NSIT Comparison

ACLX vs NSIT Comparison

Compare ACLX & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • NSIT
  • Stock Information
  • Founded
  • ACLX 2015
  • NSIT 1988
  • Country
  • ACLX United States
  • NSIT United States
  • Employees
  • ACLX N/A
  • NSIT N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • NSIT EDP Services
  • Sector
  • ACLX Health Care
  • NSIT Technology
  • Exchange
  • ACLX Nasdaq
  • NSIT Nasdaq
  • Market Cap
  • ACLX 4.4B
  • NSIT 3.4B
  • IPO Year
  • ACLX 2022
  • NSIT 1995
  • Fundamental
  • Price
  • ACLX $85.09
  • NSIT $108.68
  • Analyst Decision
  • ACLX Strong Buy
  • NSIT Buy
  • Analyst Count
  • ACLX 12
  • NSIT 3
  • Target Price
  • ACLX $113.08
  • NSIT $183.00
  • AVG Volume (30 Days)
  • ACLX 558.5K
  • NSIT 333.5K
  • Earning Date
  • ACLX 11-07-2025
  • NSIT 10-30-2025
  • Dividend Yield
  • ACLX N/A
  • NSIT N/A
  • EPS Growth
  • ACLX N/A
  • NSIT N/A
  • EPS
  • ACLX N/A
  • NSIT 4.21
  • Revenue
  • ACLX $56,979,000.00
  • NSIT $8,355,589,000.00
  • Revenue This Year
  • ACLX N/A
  • NSIT $0.41
  • Revenue Next Year
  • ACLX $210.73
  • NSIT $4.96
  • P/E Ratio
  • ACLX N/A
  • NSIT $25.87
  • Revenue Growth
  • ACLX N/A
  • NSIT N/A
  • 52 Week Low
  • ACLX $47.86
  • NSIT $105.78
  • 52 Week High
  • ACLX $107.37
  • NSIT $213.05
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 54.28
  • NSIT 37.65
  • Support Level
  • ACLX $82.64
  • NSIT $107.12
  • Resistance Level
  • ACLX $94.07
  • NSIT $111.54
  • Average True Range (ATR)
  • ACLX 3.64
  • NSIT 2.80
  • MACD
  • ACLX -0.81
  • NSIT 0.67
  • Stochastic Oscillator
  • ACLX 21.43
  • NSIT 50.04

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.

Share on Social Networks: